• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

低功能性肝脏成像评分与肝细胞癌肝切除术后的不良预后相关。

Low functional liver imaging score is associated with poor prognosis following hepatectomy for hepatocellular carcinoma.

作者信息

Sakai Nozomu, Takayashiki Tsukasa, Takano Shigetsugu, Suzuki Daisuke, Ohtsuka Masayuki

机构信息

Department of General Surgery, Graduate School of Medicine, Chiba University, 1-8-1 Inohana, Chuo-ku, Chiba, 260-8670, Japan.

出版信息

Sci Rep. 2024 Dec 28;14(1):31290. doi: 10.1038/s41598-024-82741-9.

DOI:10.1038/s41598-024-82741-9
PMID:39732922
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11682446/
Abstract

Liver function affects the prognosis of patients with hepatocellular carcinoma (HCC). This study aimed to investigate the prognostic impact of the functional liver imaging score (FLIS), assessed using gadoxetic acid-enhanced magnetic resonance imaging, on long-term outcomes following hepatectomy for HCC. The FLIS was assessed in 235 patients who underwent initial hepatectomy for HCC. The relationship between FLIS and prognosis was retrospectively analyzed. The FLIS was 6 in 185, and 2-5 in 50, patients. The 5-year recurrence-free and overall survival rates were 43.6% and 76.4% in patients with an FLIS of 6, and 23.0% and 42.4% in patients with an FLIS of 2-5, respectively; both recurrence-free and overall survival were significantly better in patients with an FLIS of 6 (P = 0.012 and 0.001, respectively). Multivariable analyses revealed that microvascular invasion (hazard ratio: 3.611; P = 0.002) and an FLIS of 2-5 (hazard ratio: 2.558; P = 0.027) were independently associated with shorter overall survival. After propensity-score matching, overall survival was significantly better in patients with an FLIS of 6. A low FLIS was significantly associated with poor prognosis following initial hepatectomy for HCC, suggesting that surgical indications must be carefully considered in patients with a low FLIS.

摘要

肝功能影响肝细胞癌(HCC)患者的预后。本研究旨在探讨使用钆塞酸二钠增强磁共振成像评估的功能性肝脏影像评分(FLIS)对HCC肝切除术后长期预后的影响。对235例行初次HCC肝切除术的患者进行了FLIS评估。回顾性分析FLIS与预后的关系。185例患者的FLIS为6分,50例患者的FLIS为2 - 5分。FLIS为6分的患者5年无复发生存率和总生存率分别为43.6%和76.4%,FLIS为2 - 5分的患者分别为23.0%和42.4%;FLIS为6分的患者无复发生存率和总生存率均显著更好(P分别为0.012和0.001)。多变量分析显示,微血管侵犯(风险比:3.611;P = 0.002)和FLIS为2 - 5分(风险比:2.558;P = 0.027)与较短的总生存期独立相关。倾向评分匹配后,FLIS为6分的患者总生存期显著更好。低FLIS与初次HCC肝切除术后的不良预后显著相关,提示对于FLIS低的患者必须仔细考虑手术指征。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/86b1/11682446/93ce7aee3643/41598_2024_82741_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/86b1/11682446/7e278e9123ad/41598_2024_82741_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/86b1/11682446/1df42d7e1da6/41598_2024_82741_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/86b1/11682446/93ce7aee3643/41598_2024_82741_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/86b1/11682446/7e278e9123ad/41598_2024_82741_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/86b1/11682446/1df42d7e1da6/41598_2024_82741_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/86b1/11682446/93ce7aee3643/41598_2024_82741_Fig3_HTML.jpg

相似文献

1
Low functional liver imaging score is associated with poor prognosis following hepatectomy for hepatocellular carcinoma.低功能性肝脏成像评分与肝细胞癌肝切除术后的不良预后相关。
Sci Rep. 2024 Dec 28;14(1):31290. doi: 10.1038/s41598-024-82741-9.
2
Preoperative assessment of liver regeneration using T1 mapping and the functional liver imaging score derived from Gd-EOB-DTPA-enhanced magnetic resonance for patient with hepatocellular carcinoma after hepatectomy.使用T1映射和基于钆塞酸二钠增强磁共振成像得出的功能性肝脏成像评分对肝癌肝切除术后患者进行肝脏再生的术前评估。
Front Immunol. 2025 Jan 30;16:1516848. doi: 10.3389/fimmu.2025.1516848. eCollection 2025.
3
Functional Liver Imaging Score Derived from Gadoxetic Acid-enhanced MRI Predicts Cachexia and Prognosis in Hepatocellular Carcinoma Patients.钆塞酸增强 MRI 衍生的功能性肝脏成像评分预测肝细胞癌患者恶病质和预后。
Curr Med Sci. 2024 Oct;44(5):1018-1025. doi: 10.1007/s11596-024-2930-y. Epub 2024 Sep 27.
4
Functional liver imaging score (FLIS) can predict adverse events in HCC patients.功能肝脏成像评分(FLIS)可预测 HCC 患者的不良事件。
Eur J Radiol. 2024 Nov;180:111695. doi: 10.1016/j.ejrad.2024.111695. Epub 2024 Aug 23.
5
Gadoxetic acid-enhanced MRI of macrotrabecular-massive hepatocellular carcinoma and its prognostic implications.钆塞酸二钠增强磁共振成像对巨小梁型-大块型肝细胞癌的诊断及其预后意义
J Hepatol. 2021 Jan;74(1):109-121. doi: 10.1016/j.jhep.2020.08.013. Epub 2020 Aug 18.
6
T mapping on gadoxetic acid-enhanced MR imaging predicts recurrence of hepatocellular carcinoma after hepatectomy.钆塞酸增强磁共振成像上的 T 映射预测肝癌切除术后的复发。
Eur J Radiol. 2018 Jun;103:25-31. doi: 10.1016/j.ejrad.2018.03.027. Epub 2018 Mar 28.
7
Surgical Indications for Hepatocellular Carcinoma with Non-hypervascular Hypointense Nodules Detected by Gd-EOB-DTPA-Enhanced MRI.钆塞酸二钠增强 MRI 检出的非富血供低信号结节的肝细胞癌手术适应证。
Ann Surg Oncol. 2020 Sep;27(9):3344-3353. doi: 10.1245/s10434-020-08419-4. Epub 2020 Apr 3.
8
Functional Liver Imaging Score (FLIS) as imaging parameter for predicting post-hepatectomy complications in patients with liver cirrhosis.功能性肝脏成像评分(FLIS)作为预测肝硬化患者肝切除术后并发症的成像参数。
Acta Radiol. 2025 Feb;66(2):208-217. doi: 10.1177/02841851241299088. Epub 2024 Dec 26.
9
A functional liver imaging score for preoperative prediction of liver failure after hepatocellular carcinoma resection.一种用于预测肝细胞癌切除术后肝衰竭的术前肝功能成像评分。
Eur Radiol. 2022 Aug;32(8):5623-5632. doi: 10.1007/s00330-022-08656-z. Epub 2022 Mar 16.
10
Prediction of post-hepatectomy liver failure using gadoxetic acid-enhanced magnetic resonance imaging for hepatocellular carcinoma with portal vein invasion.基于钆塞酸增强磁共振成像预测伴有门静脉侵犯的肝细胞癌肝切除术后肝衰竭。
Eur J Radiol. 2020 Sep;130:109189. doi: 10.1016/j.ejrad.2020.109189. Epub 2020 Jul 24.

本文引用的文献

1
Factors affecting overall survival and disease-free survival after surgery for hepatocellular carcinoma: a nomogram-based prognostic model-a Western European multicenter study.影响肝癌手术后总生存和无病生存的因素:基于列线图的预后模型——一项西欧多中心研究。
Updates Surg. 2024 Jan;76(1):57-69. doi: 10.1007/s13304-023-01656-8. Epub 2023 Oct 15.
2
Remnant liver function is associated with long-term survival in patients with hepatocellular carcinoma undergoing hepatectomy.残肝功能与接受肝切除术的肝细胞癌患者的长期生存相关。
Sci Rep. 2023 Sep 20;13(1):15637. doi: 10.1038/s41598-023-42929-x.
3
Pembrolizumab in combination with gemcitabine and cisplatin compared with gemcitabine and cisplatin alone for patients with advanced biliary tract cancer (KEYNOTE-966): a randomised, double-blind, placebo-controlled, phase 3 trial.
帕博利珠单抗联合吉西他滨和顺铂与单纯吉西他滨和顺铂治疗晚期胆道癌患者的比较(KEYNOTE-966):一项随机、双盲、安慰剂对照、3 期临床试验。
Lancet. 2023 Jun 3;401(10391):1853-1865. doi: 10.1016/S0140-6736(23)00727-4. Epub 2023 Apr 16.
4
The relationship between echocardiographic parameters and albumin bilirubin (ALBI) score in patients with isolated secundum type atrial septal defect.单纯继发孔型房间隔缺损患者超声心动图参数与白蛋白胆红素(ALBI)评分之间的关系。
Echocardiography. 2023 Apr;40(4):350-358. doi: 10.1111/echo.15556. Epub 2023 Mar 27.
5
Perspectives on the Underlying Etiology of HCC and Its Effects on Treatment Outcomes.肝癌潜在病因及其对治疗结果影响的观点
J Hepatocell Carcinoma. 2023 Mar 10;10:413-428. doi: 10.2147/JHC.S347959. eCollection 2023.
6
Baseline ALBI Grade Predicts Benefits After Splenectomy for Cirrhotic Patients with Hypersplenism.基线 ALBI 分级可预测肝硬化伴脾功能亢进患者脾切除术后的获益。
J Gastrointest Surg. 2023 Jun;27(6):1130-1140. doi: 10.1007/s11605-023-05610-2. Epub 2023 Feb 9.
7
Inter-reader reliability of functional liver imaging score derived from gadoxetic acid-enhanced MRI: a meta-analysis.钆塞酸二钠增强MRI衍生的功能性肝脏成像评分的阅片者间可靠性:一项荟萃分析。
Abdom Radiol (NY). 2023 Mar;48(3):886-894. doi: 10.1007/s00261-022-03785-x. Epub 2022 Dec 28.
8
Application of the ALBI Scoring System for Mortality Outcome Prediction in Patients with Hypertrophic Cardiomyopathy.ALBI 评分系统在肥厚型心肌病患者死亡率预后预测中的应用。
Glob Heart. 2022 Oct 11;17(1):73. doi: 10.5334/gh.1163. eCollection 2022.
9
Determining the efficacy of functional liver imaging score (FLIS) obtained from gadoxetic acid-enhanced MRI in patients with chronic liver disease and liver cirrhosis: the relationship between Albumin-Bilirubin (ALBI) grade and FLIS.探讨慢性肝病和肝硬化患者从钆塞酸增强 MRI 获得的功能肝脏成像评分(FLIS)的疗效:ALBI 分级与 FLIS 的关系。
Abdom Radiol (NY). 2022 Jul;47(7):2325-2334. doi: 10.1007/s00261-022-03557-7. Epub 2022 Jun 7.
10
Gadoxetic acid-enhanced MRI-derived functional liver imaging score (FLIS) and spleen diameter predict outcomes in ACLD.钆塞酸增强 MRI 衍生的功能性肝脏成像评分(FLIS)和脾脏直径可预测 ACLD 的结局。
J Hepatol. 2022 Oct;77(4):1005-1013. doi: 10.1016/j.jhep.2022.04.032. Epub 2022 May 4.